Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia. 2007

C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek

UI MeSH Term Description Entries
D007438 Introns Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes. Intervening Sequences,Sequences, Intervening,Intervening Sequence,Intron,Sequence, Intervening
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D011495 Histone-Lysine N-Methyltransferase An enzyme that catalyzes the methylation of the epsilon-amino group of lysine residues in proteins to yield epsilon mono-, di-, and trimethyllysine. Protein Lysine Methyltransferase,Protein Methylase III,Protein Methyltransferase III,Histone-Lysine Methyltransferase,Histone Lysine Methyltransferase,Histone Lysine N Methyltransferase,Methyltransferase, Histone-Lysine,Methyltransferase, Protein Lysine,N-Methyltransferase, Histone-Lysine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002880 Chromosomes, Human, Pair 11 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 11
D002888 Chromosomes, Human, Pair 19 A specific pair of GROUP F CHROMOSOMES of the human chromosome classification. Chromosome 19
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons

Related Publications

C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
January 2011, The Korean journal of laboratory medicine,
C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
June 2010, American journal of hematology,
C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
January 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
June 2011, British journal of haematology,
C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
July 2015, Cureus,
C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
January 2017, British journal of haematology,
C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
February 2010, Cancer genetics and cytogenetics,
C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
July 2016, Leukemia,
C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
April 1995, Blood,
C Meyer, and T Burmeister, and S Strehl, and B Schneider, and D Hubert, and O Zach, and O Haas, and T Klingebiel, and T Dingermann, and R Marschalek
February 2003, Cancer genetics and cytogenetics,
Copied contents to your clipboard!